ABROCITINIB vs TOFACITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ABROCITINIB vs TOFACITINIB: Safety Overview
| Metric | ABROCITINIB | TOFACITINIB |
|---|---|---|
| Total FAERS Reports | 3,170 | 155,647 |
| Deaths Reported | 57 | 7,847 |
| Death Rate | 1.8% | 5.0% |
| Hospitalizations | 329 | 21,976 |
| Average Patient Age | 48.5 yrs | 57.6 yrs |
| % Female Patients | 53.9% | 81.6% |
| FDA Approval Date | Jan 14, 2022 | Aug 19, 2021 |
| Manufacturer | U.S. Pharmaceuticals | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |